Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO
2007

New Inhibitor for Caspase-3

publication Evidence: high

Author Information

Author(s): Yoshimori Atsushi, Sakai Junichi, Sunaga Satoshi, Kobayashi Takanobu, Takahashi Satoshi, Okita Naoyuki, Takasawa Ryoko, Tanuma Sei-ichi

Hypothesis

Can a novel peptide inhibitor, Ac-DNLD-CHO, selectively inhibit caspase-3 over other caspases?

Conclusion

Ac-DNLD-CHO is a reliable, potent, and selective inhibitor of caspase-3, which could be useful in studying caspase-3's biological functions.

Supporting Evidence

  • Ac-DNLD-CHO inhibits caspase-3 with an IC50 of 9.89 nM.
  • The inhibitor shows approximately 80-fold selectivity for caspase-3 over caspase-7.
  • The binding mode of Ac-DNLD-CHO involves specific hydrogen bonds with caspase-3.

Takeaway

Scientists created a new medicine that can stop a specific protein called caspase-3 from working, which is important for cell death. This could help in treating diseases where too many cells die.

Methodology

The study involved computational docking, site-directed mutagenesis, and enzyme kinetic analyses to evaluate the inhibitor's specificity and potency.

Digital Object Identifier (DOI)

10.1186/1471-2210-7-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication